NCT06142838|Unknown
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
PHARM-ADHERE
Loading search results
PHARM-ADHERE
Sponsor study identifier
interventional
1,600
1 country
1
Study Start
October 3, 2023
Actual (reported)Primary Completion
May 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The goal of this clinical trial is to evaluate a community pharmacist intervention aimed at improving medication adherence in patients starting newly prescribed medication for cardiovascular disease prevention. The main questions it aims to answer are:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 3, 2023
Actual (reported)November 15, 2023
Actual (reported)November 22, 2023
Actual (reported)May 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
NIH Patient Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)
Patient-reported measure of medication adherence
At 6 weeks and at 12 weeks follow-up
Medication Possession Ratio (MPR)
Over 26 weeks post-baseline
Discontinuation rate
Over 26 weeks post-baseline
Medication knowledge questionnaire
At 6 weeks and at 12 weeks follow-up
Beliefs about Medicines Questionnaire (BMQ-Specific)
At 6 weeks and at 12 weeks follow-up
Treatment response
At baseline and at 12 weeks follow-up
Community pharmacist intervention
Usual care
The community pharmacist intervention comprises 2 parts: (1) first prescription counseling (oral and written information), and (2) a follow-up consultation (by telephone or in person) 7-14 days later, to identify problems with adherence/treatment
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pharmaceutical Care Unit (Ghent University)
Ghent, Belgium
First Submitted
November 15, 2023
First Posted
November 22, 2023
Study Start
October 3, 2023
Actual (reported)Primary Completion
May 31, 2024
Estimated (date passed)Cardiac Rehabilitation Program in Patients with Cardiovascular Disease
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 22, 2023
Record last verified: 2023-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: